Moneycontrol PRO
you are here: HomeNewsIndia

Coronavirus impact | India's domestic air passenger traffic fell by 11.8% in March: IATA

The International Air Transport Association (IATA), however, said global passenger traffic dived 52.9 percent compared to the same period a year ago.

April 29, 2020 / 07:02 PM IST

Indian domestic air passenger traffic fell by 11.8 percent in March as compared to the corresponding month last year, indicating the impact of COVID-19 on the country's aviation sector, stated global airlines body IATA on Wednesday.

The International Air Transport Association (IATA), however, said global passenger traffic dived 52.9 percent compared to the same period a year ago.

India has been under lockdown since March 25 to curb coronavirus, which has killed more than 1,000 people in the country till now. All commercial passenger flights have been suspended for this period.

Coronavirus India News LIVE Updates

The IATA, which represents around 300 airlines accounting for 82 percent of the global air traffic, measures passenger growth in terms of revenue passenger kilometers (RPKs), which is calculated by multiplying the number of passengers with the distance travelled by them.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"The experience of the domestic Russia and India markets currently sits in contrast with the outcomes elsewhere. Passenger volumes in domestic Russia fell by 15.4 percent YoY in March, and by 11.8 percent YoY in India; both represent relatively resilient outcomes," the IATA said in its statement on Wednesday.

"In annual terms, capacity increased in both markets this month (March). However, the COVID-19 outbreak began to impact these countries later than elsewhere and lockdown also lagged the experience of many other nations. As a result, the relative out-performance in traffic volumes may not be sustained in April, with larger declines still to come," it stated.

Follow our full coverage of the coronavirus pandemic here.

first published: Apr 29, 2020 06:55 pm